BioNTech

BioNTech三月展望：战略转型与专利博弈并行

March 1, 2026

BioNTech’s Financial Milestone Approaches as Strategic Pivot Continues

February 27, 2026

BioNTech财报前夜：专利战火重燃，转型之路迎关键考验

February 26, 2026

专利战火再起：BioNTech在美国法院起诉Moderna新疫苗侵权

kashif hafeez - February 25, 2026

BioNTech再掀专利诉讼战，肿瘤管线转型同步推进

kashif hafeez - February 22, 2026

BioNTech股价再获强心剂：真实世界研究证实加强针效力

kashif hafeez - February 20, 2026

BioNTech股价：关键数据发布前的蓄势期

angelina - February 10, 2026

BioNTech转型攻坚：后疫情时代的生死时速

angelina - February 6, 2026

分析师为BioNTech股价降温：抗癌管线加速推进，但短期估值已高？

kashif hafeez - February 5, 2026

BioNTech Shifts Gears: Strategic Pivot to Oncology Gains Momentum

February 4, 2026

BioNTech股价遭遇评级下调压力

Brett Shapiro - February 4, 2026

BioNTech’s Strategic Pivot: Oncology Pipeline Gains Momentum

February 3, 2026

分析师观点现分歧，BioNTech股价涨势遇阻

Brett Shapiro - February 3, 2026

BioNTech Shares Face Headwinds Amid Strategic Shifts

February 2, 2026

BioNTech战略转型：押注肿瘤治疗新赛道

kashif hafeez - February 2, 2026

123...6 Page 2 of 6